Search results
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 13 hours agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
Maryland-based Novavax soars on big vaccine deal - WTOP News
WTOP Washington· 10 hours agoGaithersburg, Maryland-based Novavax has signed a $1.2 billion licensing agreement with French...
Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 losses | Invezz
Invezz· 13 hours agoNovavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the...
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with
Guru Focus· 5 hours agoThe company, a prominent player in the biotechnology sector focusing on the development of vaccines, reported a net loss of $147.55 million with a loss per share of $1.05.
Novavax Inc (NVAX) Q1 2024 Earnings: Navigating Challenges with Strategic Partnerships and Cost ...
GuruFocus.com via Yahoo Finance· 5 hours agoChallenges and Forward Strategy The company is not without its challenges, notably the ongoing need to manage high operational costs and navigate the complex regulatory landscape for
Novavax shares surge on new $1.4 billion deal with Sanofi
Market Watch· 14 hours agoNovavax will also be entitled to a further $200 million in additional launch and sales milestone...
Novavax stock soars 40% on Sanofi partnership By Investing.com
Investing.com· 14 hours agoFor the first quarter, Novavax reported a first-quarter loss per share of $1.05, wider than the...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
CBS 47 Fresno· 16 hours agoAnnounces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop ...
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize...
Benzinga· 17 hours agoSanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines ...
France’s Sanofi in COVID-19 vaccine deal with Novavax
WSAU Wausau· 16 hours agoPARIS (Reuters) - Sanofi on Friday announced it has reached a licensing agreement with Novavax to...
